The association of MHC with autoimmune diseases: Understanding the pathogenesis of autoimmune diabetes

被引:32
|
作者
Ridgway, WM [1 ]
Fathman, CG [1 ]
机构
[1] Stanford Univ, Dept Med, Div Rheumatol & Immunol, Sch Med, Stanford, CA 94305 USA
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1998年 / 86卷 / 01期
关键词
MHC; NOD mice; thymic selection; autoimmunity; TCR avidity;
D O I
10.1006/clin.1997.4449
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The current paradigm of MHC and disease association is efficient binding of autoantigens by disease-associated MHC molecules leading to a T cell-mediated immune response and resultant autoimmune sequelae, Data presented here offer a different model for this association of MHC with autoimmune diabetes. This new explanation suggests that the association of MHC with autoimmunity results from "altered" thymic selection in which high-affinity self-reactive (potentially autoreactive) T cells escape negative selection. This model offers an explanation for the requirement of homozygous MHC class II expression in NOD mice (and in man) in susceptibility to IDDM. (C) 1998 Academic Press.
引用
收藏
页码:3 / 10
页数:8
相关论文
共 50 条
  • [21] Progress in Understanding Type 1 Diabetes Through Its Genetic Overlap with Other Autoimmune Diseases
    Roizen, Jeffrey D.
    Bradfield, Jonathan P.
    Hakonarson, Hakon
    CURRENT DIABETES REPORTS, 2015, 15 (11)
  • [22] The infectious origin of autoimmune diseases: New concepts to understand the pathogenesis of rheumatic diseases
    Zepp, F
    REVUE DU RHUMATISME, 1997, 64 (10): : S153 - S155
  • [23] The role of the BTLA-HVEM complex in the pathogenesis of autoimmune diseases
    Wojciechowicz, Karolina
    Spodzieja, Marta
    Lisowska, Katarzyna A.
    Wardowska, Anna
    CELLULAR IMMUNOLOGY, 2022, 376
  • [24] Pathogenesis of autoimmune hepatitis
    McFarlane, IG
    BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (5-6) : 255 - 263
  • [25] Autoimmune diseases in type 1A diabetes mellitus
    Ferreira-Hermosillo, Aldo
    Antonio Molina-Ayala, Mario
    REVISTA MEDICA DE CHILE, 2015, 143 (08) : 1042 - 1049
  • [26] Use of MHC II Structural Features in the Design of Vaccines for Organ-Specific Autoimmune Diseases
    Moustakas, Antonis K.
    Papadopoulos, George K.
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (28) : 3262 - 3273
  • [27] Mouse Models of Autoimmune Diseases - Autoimmune Myocarditis
    Mueller, Anna-Maria
    Fischer, Andrea
    Katus, Hugo A.
    Kaya, Ziya
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (18) : 2498 - 2512
  • [28] Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
    Popoviciu, Mihaela Simona
    Kaka, Nirja
    Sethi, Yashendra
    Patel, Neil
    Chopra, Hitesh
    Cavalu, Simona
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (03):
  • [29] Advances in understanding the pathogenesis of autoimmune disorders: focus on chemokines and lymphocyte trafficking
    Comerford, Iain
    Kara, Ervin E.
    McKenzie, Duncan R.
    McColl, Shaun R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (03) : 329 - 341
  • [30] THE USE OF MHC-BINDING PEPTIDES IN THE IMMUNOTHERAPY OF AUTOIMMUNE-DISEASES - A COMMENTARY
    WRAITH, DC
    RESEARCH IN IMMUNOLOGY, 1991, 142 (5-6): : 505 - 508